These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27739029)

  • 41. Overexpression of CASS4 promotes invasion in non-small cell lung cancer by activating the AKT signaling pathway and inhibiting E-cadherin expression.
    Li A; Zhang W; Xia H; Miao Y; Zhou H; Zhang X; Dong Q; Li Q; Qiu X; Wang E
    Tumour Biol; 2016 Nov; 37(11):15157-15164. PubMed ID: 27677288
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Kinesin superfamily protein 21B acts as an oncogene in non-small cell lung cancer.
    Sun ZG; Pan F; Shao JB; Yan QQ; Lu L; Zhang N
    Cancer Cell Int; 2020; 20():233. PubMed ID: 32536821
    [TBL] [Abstract][Full Text] [Related]  

  • 43. ANGPTL4 Correlates with NSCLC Progression and Regulates Epithelial-Mesenchymal Transition via ERK Pathway.
    Zhu X; Guo X; Wu S; Wei L
    Lung; 2016 Aug; 194(4):637-46. PubMed ID: 27166634
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Kinesin family member 2A promotes cancer cell viability, mobility, stemness, and chemoresistance to cisplatin by activating the PI3K/AKT/VEGF signaling pathway in non-small cell lung cancer.
    Xu L; Zhang X; Wang Z; Zhao X; Zhao L; Hu Y
    Am J Transl Res; 2021; 13(4):2060-2076. PubMed ID: 34017375
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effect of microRNA-135a on Cell Proliferation, Migration, Invasion, Apoptosis and Tumor Angiogenesis Through the IGF-1/PI3K/Akt Signaling Pathway in Non-Small Cell Lung Cancer.
    Zhou Y; Li S; Li J; Wang D; Li Q
    Cell Physiol Biochem; 2017; 42(4):1431-1446. PubMed ID: 28715819
    [TBL] [Abstract][Full Text] [Related]  

  • 46. MiR-139-5p Targetedly Regulates YAF2 and Mediates the AKT/P38 MAPK Signaling Pathway to Alleviate the Metastasis of Non-Small Cell Lung Cancer Cells and Their Resistance Against Cisplatin.
    Yan Y; Jin X; Sun H; Pang S; Kong X; Bu J; Xu S
    Cancer Manag Res; 2021; 13():3639-3650. PubMed ID: 33981163
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HCRP1 expression status is a significant prognostic marker in oral and oropharyngeal cancer.
    Perisanidis C; Savarese-Brenner B; Würger T; Wrba F; Huynh A; Schopper C; Kornek G; Selzer E; Ewers R; Psyrri A; Krainer M; Filipits M
    Oral Dis; 2013 Mar; 19(2):206-11. PubMed ID: 22891969
    [TBL] [Abstract][Full Text] [Related]  

  • 48. TRIM31 is downregulated in non-small cell lung cancer and serves as a potential tumor suppressor.
    Li H; Zhang Y; Zhang Y; Bai X; Peng Y; He P
    Tumour Biol; 2014 Jun; 35(6):5747-52. PubMed ID: 24566900
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Gefitinib sensitization of cisplatin-resistant wild-type EGFR non-small cell lung cancer cells.
    Li A; Cao W; Liu X; Zhang Y; Ma Y; Xu R; Zhang R; Liu X; Zhou S; Wang R; Liu J; Tang X
    J Cancer Res Clin Oncol; 2020 Jul; 146(7):1737-1749. PubMed ID: 32342201
    [TBL] [Abstract][Full Text] [Related]  

  • 50. C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer.
    Wei L; Liu Y; Ma Y; Ding C; Zhang H; Lu Z; Gu Z; Zhu C
    Cell Cycle; 2019 Dec; 18(24):3456-3471. PubMed ID: 31731888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Suppression of CX3CL1 by miR-497-5p inhibits cell growth and invasion through inactivating the ERK/AKT pathway in NSCLC cells.
    Tang W; Jia P; Zuo L; Zhao J
    Cell Cycle; 2022 Aug; 21(16):1697-1709. PubMed ID: 35485293
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ataxia-telangiectasia group D complementing gene (ATDC) promotes lung cancer cell proliferation by activating NF-κB pathway.
    Tang ZP; Dong QZ; Cui QZ; Papavassiliou P; Wang ED; Wang EH
    PLoS One; 2013; 8(6):e63676. PubMed ID: 23776433
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-379 acts as a tumor suppressor in non-small cell lung cancer by targeting the IGF‑1R-mediated AKT and ERK pathways.
    Zhou F; Nie L; Feng D; Guo S; Luo R
    Oncol Rep; 2017 Sep; 38(3):1857-1866. PubMed ID: 28731178
    [TBL] [Abstract][Full Text] [Related]  

  • 54. NOVA1 promotes NSCLC proliferation and invasion by activating Wnt/β-catenin signaling.
    Qu L; Tian Y; Wang F; Li Z
    BMC Cancer; 2022 Oct; 22(1):1091. PubMed ID: 36284263
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Depleted aldehyde dehydrogenase 1A1 (ALDH1A1) reverses cisplatin resistance of human lung adenocarcinoma cell A549/DDP.
    Wei Y; Wu S; Xu W; Liang Y; Li Y; Zhao W; Wu J
    Thorac Cancer; 2017 Jan; 8(1):26-32. PubMed ID: 27813328
    [TBL] [Abstract][Full Text] [Related]  

  • 56. α-Lipoic acid inhibits human lung cancer cell proliferation through Grb2-mediated EGFR downregulation.
    Yang L; Wen Y; Lv G; Lin Y; Tang J; Lu J; Zhang M; Liu W; Sun X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):325-331. PubMed ID: 28993193
    [TBL] [Abstract][Full Text] [Related]  

  • 57. HCRP1, a novel gene that is downregulated in hepatocellular carcinoma, encodes a growth-inhibitory protein.
    Xu Z; Liang L; Wang H; Li T; Zhao M
    Biochem Biophys Res Commun; 2003 Nov; 311(4):1057-66. PubMed ID: 14623289
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of FASN suppresses the malignant biological behavior of non-small cell lung cancer cells via deregulating glucose metabolism and AKT/ERK pathway.
    Chang L; Fang S; Chen Y; Yang Z; Yuan Y; Zhang J; Ye L; Gu W
    Lipids Health Dis; 2019 May; 18(1):118. PubMed ID: 31122252
    [TBL] [Abstract][Full Text] [Related]  

  • 59. FoxM1 expression is significantly associated with cisplatin-based chemotherapy resistance and poor prognosis in advanced non-small cell lung cancer patients.
    Wang Y; Wen L; Zhao SH; Ai ZH; Guo JZ; Liu WC
    Lung Cancer; 2013 Feb; 79(2):173-9. PubMed ID: 23177020
    [TBL] [Abstract][Full Text] [Related]  

  • 60. MiR-4299 suppresses non-small cell lung cancer cell proliferation, migration and invasion through modulating PTEN/AKT/PI3K pathway.
    Yang WB; Zhang WP; Shi JL; Wang JW
    Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3408-3414. PubMed ID: 29917192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.